National Thrombosis Week | 1st – 6th May 2017| Prevention & Protection from Venous Thromboembolism (VTE)

Evidence on safety, efficacy of newer oral anticoagulants in patients with VTE continues to mount

In patients with venous thromboembolism, treatment with non-vitamin K oral anticoagulants is safer than warfarin without compromising efficacy, according to a speaker at the International Symposium on Endovascular Therapy.

Compared with warfarin, the non-vitamin K oral anticoagulants have lower rates of major bleeding in patients with VTE, and are more convenient because treatment does not require routine monitoring, Ian Del Conde, MD, FACC, section head of vascular medicine at Miami Cardiac and Vascular Institute, said here.

"There is now plenty of evidence about what these drugs do and don’t do, and how patients behave on them," he said.

Read the full Article